Healthcare
NBTX
Nanobiotix S.A.
$41.23-8.70%
Add to Watchlist
Loading chart...
About Nanobiotix S.A.
Nanobiotix is a biotechnology company developing cancer treatments. Its main product in development is NBTXR3, an injection made of tiny particles of the metal hafnium oxide that works with radiation therapy to treat various types of cancer including lung, liver, and pancreatic cancer. The company is based in Paris and has partnered with another company to sell NBTXR3 in several Asian countries.
Full research is for ConvictionStocks members
Get Full AccessAnalyst Coverage
Full research is for ConvictionStocks members
Get Full AccessRecent News
Full research is for ConvictionStocks members
Get Full AccessGet the free weekly market digest
The week's biggest movers, every Sunday. No spam.
Related Research
More Healthcare stocks to explore